To Evaluate the Safety, Tolerability, Pharmacokinetics and the Effect of Food on the Hemay5259 Sustained-release Tablets in Healthy Subjects.

Starting soon · Phase 1 · Has a placebo group

Conditions studied: Pharmacokinetics

In brief

Evaluation of the pharmacokinetics of Hemay 5259 sustained-release tablets in healthy human subjects

Key facts

Study ID

NCT07703904

Run by

Hemay Pharmaceutical PTY. LTD.

People needed

32

Starts

2026-07-01

Expected to finish

2026-10-31

Last updated by the study team

2026-07-15

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

Where it is running

• Scientia Clinical Research Ltd — Randwick, New South Wales, Australia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.